Patient engagement through advisory boards, surveys, and listening sessions can help address industry challenges such as ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

Shares of major US drugmakers plunged Monday after reports surfaced that the FDA’s leading vaccine official was forced out as part of a shakeup at federal health agencies ordered by the ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how ...

Advances recognized by science’s most lucrative awards include Large Hadron Collider experiments and groundbreaking ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...